Swiss-based InVirtuoLabs raises €2.85M to accelerate drug development with AI - Silicon Canals

Silicon Canals

Factuality

Ownership

Swiss-based InVirtuoLabs raises €2.85M to accelerate drug development with AI - Silicon Canals

Lugano, Switzerland-based InVirtuoLabs, a new-gen lab for drug discovery, has secured €2.85M in its first funding round. The company will use the funds to drastically reduce the time and cost of drug development, making treatments more accessible. In the next 18 months, the startup plans rapid expansion, to strengthen the team, initiate strategic collaborations, and expand the capabilities of the platform. InVirtuoLabs: A new-gen lab for drug di…